Glaukos
GKOS · Health Care Equipment
$178.88
1.2%LeMaitre Vascular
LMAT · Health Care Equipment
$84.45
1.0%The short version
- Glaukos is the larger business, with $507M of revenue in fiscal 2025 against $250M for LeMaitre Vascular, about 2.0 times as much.
- Glaukos grew revenue faster (32.3%, against 13.5%).
- LeMaitre Vascular kept more of each dollar of sales as operating profit (27.2% operating margin, against −39.3% operating margin).
- LeMaitre Vascular turned more of its sales into free cash flow (29.8% FCF margin, against −4.4% FCF margin).
| Latest fiscal year | GKOS · FY25 | LMAT · FY25 |
|---|---|---|
| Size | ||
| Market cap | $10.5B | $2.1B |
| Revenue | $507M | $250M |
| Free cash flow | −$22.5M | $74.5M |
| Net income | −$188M | $57.7M |
| Growth | ||
| Revenue growth | 32.3% | 13.5% |
| 5-year growth | 17.7% | 14.0% |
| Share count change | 8.4% | 0.7% |
| Profitability | ||
| Gross margin | 55.7% | 71.5% |
| Operating margin | −39.3% | 27.2% |
| Net margin | −37.0% | 23.1% |
| FCF margin | −4.4% | 29.8% |
| Return on capital | — | 25.5% |
| Return on equity | −26.4% | 15.8% |
| Balance sheet | ||
| Net debt | — | −$191M |
| Net debt / EBITDA | — | −2.4x |
| Dividends and buybacks | $0.0M | $19.9M |
| Valuation & quality | ||
| P/E | — | 29.6x |
| Piotroski F-score | — | 5 |
FY16
GKOS $114M
LMAT $89.2M
FY17
GKOS $159M
LMAT $101M
FY18
GKOS $181M
LMAT $106M
FY19
GKOS $237M
LMAT $117M
FY20
GKOS $225M
LMAT $129M
FY21
GKOS $294M
LMAT $154M
FY22
GKOS $283M
LMAT $162M
FY23
GKOS $315M
LMAT $194M
FY24
GKOS $384M
LMAT $220M
FY25
GKOS $507M
LMAT $250M
GKOS
LMAT
FY16
GKOS 3.7%
LMAT 18.3%
FY17
GKOS −1.4%
LMAT 20.9%
FY18
GKOS −7.2%
LMAT 26.7%
FY19
GKOS −21.2%
LMAT 18.1%
FY20
GKOS −54.9%
LMAT 22.3%
FY21
GKOS −11.2%
LMAT 23.6%
FY22
GKOS −29.1%
LMAT 16.6%
FY23
GKOS −40.9%
LMAT 19.0%
FY24
GKOS −31.9%
LMAT 23.8%
FY25
GKOS −39.3%
LMAT 27.2%
GKOS
LMAT
FY16
GKOS $6.0M
LMAT $14.1M
FY17
GKOS $19.8M
LMAT $16.5M
FY18
GKOS $8.6M
LMAT $16.5M
FY19
GKOS −$5.1M
LMAT $10.4M
FY20
GKOS −$29.9M
LMAT $31.8M
FY21
GKOS −$23.1M
LMAT $30.2M
FY22
GKOS −$63.4M
LMAT $22.2M
FY23
GKOS −$78.0M
LMAT $29.5M
FY24
GKOS −$67.6M
LMAT $37.2M
FY25
GKOS −$22.5M
LMAT $74.5M
GKOS
LMAT
FY16
GKOS —
LMAT —
FY17
GKOS —
LMAT —
FY18
GKOS —
LMAT —
FY19
GKOS —
LMAT —
FY20
GKOS —
LMAT —
FY21
GKOS −5.1%
LMAT —
FY22
GKOS −10.2%
LMAT —
FY23
GKOS −13.7%
LMAT —
FY24
GKOS —
LMAT 20.3%
FY25
GKOS —
LMAT 25.5%
GKOS
LMAT
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.